949892-08-4

Basic information

• Product Name: 1-Bromo-5-chloro-4-fluoro-2-methoxybenzene
• Synonyms: 1-Bromo-5-chloro-4-fluoro-2-methoxybenzene
• CAS NO: 949892-08-4
• Molecular Formula: C₇H₅BrClFO
• Molecular Weight: 239.4694032
• Mol File: 949892-08-4.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1-Bromo-5-chloro-4-fluoro-2-methoxybenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Bromo-5-chloro-4-fluoro-2-methoxybenzene(949892-08-4)
• EPA Substance Registry System: 1-Bromo-5-chloro-4-fluoro-2-methoxybenzene(949892-08-4)

Safety Data

• Hazardous Substances Data: 949892-08-4(Hazardous Substances Data)

Usage

General Description

1-Bromo-5-chloro-4-fluoro-2-methoxybenzene is an organic compound that is part of the benzene and halogenated aromatic hydrocarbon group. This chemical compound has several unique features, including a molecular weight of about 259.469 g/mol and specific identifiers such as a CAS number of 17318-08-0. Important aspects of its structure involve the presence of a benzene ring structure and several halogens such as bromine, chlorine, and fluorine, as well as a methoxy group. The compound is used in a variety of applications, particularly as a building block in synthetic chemistry. It is generally recommended to handle it with care due to its reactivity characteristics, and its uses are strictly regulated due to environmental and health considerations.

Upstream product

• 501-29-1 1-chloro-2-fluoro-4-methoxybenzene 
• 74-88-4 methyl iodide 

Downstream Products

• 949892-09-5 5-Chloro-4-fluoro-2-methoxyphenylboronic acid 

Relevant articles and documents

COMPOUNDS FOR INHIBITION OF ALPHA 4β7 INTEGRIN

The present disclosure provides a compound of Formula (I); or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), and therapeutic methods for treating inflammatory disease.

NOVEL 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE HAVING GLUCOCORTICOID RECEPTOR BINDING ACTIVITY

An object of the present invention is to synthesize a novel 1,2,3,4-tetrahydroquinoxaline derivative represented by formula (1) and to find a pharmacological action of the derivative. In the formula, the R1 represents a halogen, an alkyl, cycloalkyl, aryl or heterocyclic group, or the like; p represents 0 to 5; R2 represents a halogen, an alkyl, hydroxyl or alkoxy group, or the like; q represents 0 to 2; R3 represents hydrogen, an alkyl, alkenyl, alkylcarbonyl or arylcarbonyl group, or the like; R4 and R5 independently represent hydrogen, a halogen, an alkyl, alkenyl, alkynyl, cycloalkyl, aryl or heterocyclic group, or the like; R6 represents hydrogen, an alkyl, alkenyl, alkynyl, cycloalkyl, aryl or heterocyclic group, or the like; A represents an alkylene; R7 represents OR8, NR8R9, SR8, S(O)R8, S(O)2R8; and X represents O or S.